BioSpace News Archive

As the CDC reports that 69 percent of reported West Nile virus cases have been diagnosed with the more severe neuroinvasive disease, a scientific paper recently published in the peer-reviewed journal, Nature Communications, offers an explanation as to why some people infected with West Nile virus have no symptoms while others suffer life-threatening neuroinvasive disease.

Aerie Pharmaceuticals, Inc. announced the appointment of Luis Vargas, M.D., as Medical Director, Medical Affairs, reporting to Welyn Bui, PharmD, Aerie’s Vice President of Medical Affairs.

The global femoral stems market size is poised to grow by USD 378.6 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 4% during the forecast period.

Business Provides Hospice Services through 21 Locations Across Six States, Producing Annualized Revenue of Approximately $55 Million

At EUROISMAR 2019, Bruker Corporation announced the world’s first 1.2 GHz high-resolution, protein nuclear magnetic resonance data.

The global market for smart augmented reality (AR) glasses has struggled to take off after a few years of pilots, implementations, and a lot of hype.

Abbott (NYSE: ABT) announced that a new study, published in Lancet Neurology, found that elevated levels of a protein measured with the company’s blood test under development could help detect mild traumatic brain injuries (TBIs), even when a CT scan did not detect it

Judy Chou, Ph.D., senior vice president and global head of biotech/Berkeley site head, Bayer, Emad Fareed, partner at KPMG, and Bob Ramos, partner at Procopio, to its board of directors.

17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New York City.

Immunizations available for adults and children with no appointment needed